1231
Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
Condition(s):LeukemiaLast Updated:November 6, 2013Completed
Induction of Labor: 1298 Clinical Trials, Page 124 of 130
Hide Studies Not Open or Pending
1232
Pharmacoepigenetics of Bipolar Disorder Treatment
Condition(s):Antipsychotic Agents; Bipolar DisorderLast Updated:February 14, 2018Completed
1233
Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer
Condition(s):Dyspnea; Lung Cancer; Pulmonary Complications; Radiation FibrosisLast Updated:May 2, 2017Withdrawn
1234
Dual Task Perturbation Training for OAwMCI
Condition(s):Mild Cognitive Impairment; Old Age; DebilityLast Updated:September 27, 2021Active, not recruiting
1235
Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death
Condition(s):Neonatal SEPSISLast Updated:March 31, 2022Completed
1236
Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation
Condition(s):Substance-related DisordersLast Updated:October 7, 2021Active, not recruiting
1237
Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle
Condition(s):Obesity; SarcopeniaLast Updated:December 2, 2014Completed
1238
Perioperative Ketamine for Pain With Gastric Bypass
Condition(s):Laparoscopic Gastric Bypass Surgery; KetamineLast Updated:April 29, 2021Completed
1239
Neurocardiac Interactions Evaluated by Anatomic and Physiologic MRI Assessment
Condition(s):Ischemia; Stress, MentalLast Updated:January 9, 2018Withdrawn
1240
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia
Condition(s):Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Basophilic Leukemia; Adult Acute Eosinophilic Leukemia; Adult Acute Megakaryoblastic Leukemia; Adult Acute Monoblastic Leukemia; Adult Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With Maturation; Adult Acute Myeloid Leukemia With Minimal Differentiation; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL; Adult Acute Myeloid Leukemia Without Maturation; Adult Acute Myelomonocytic Leukemia; Adult Erythroleukemia; Adult Pure Erythroid Leukemia; Alkylating Agent-Related Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid LeukemiaLast Updated:August 20, 2015Terminated